Background: Migraine is associated with increased prevalence of cardiovascular risk factors and vascular biomarkers and migraine with aura is associated with increased risk of ischemic stroke. Lipid abnormality is a risk factor for both cardiovascular and cerebrovascular disease. The vast majority of previous studies evaluated the association between lipid levels and migraine among young and middle aged persons abroad. So far we know, no study has been conducted in Bangladesh regarding association of lipid levels with migraine. Objectives: The present study is aimed to evaluate the association between serum lipid levels in patients with migraine.
Introduction
Headache is one of the most common presenting complaints in neurology. The lifetime prevalence for any type of headache as estimated from populationbased studies is more than 90% for men and 95% for women. 1 Migraine, the second most common cause of headache, affects approximately 15% of women and 6% of men. Migraine is a chronic and common disease that presents with mild to severe recurrent headaches, accompanied by autonomic and neurologic symptoms. It is a ubiquitous familial disorder characterized by periodic, commonly unilateral, often pulsatile headaches that begins in childhood, adolescence, or early adult life and recur with diminishing frequency during advancing years. Migraine is more common among females with a ratio of male to female 1:3. 2 Migraine is associated with certain features such as sensitivity to light, sound or movement, nausea and vomiting which often accompany the headache. A useful description of migraine is a benign and recurring syndrome of headache associated with other symptoms of neurologic dysfunction in varying admixtures. Migraine can often be recognized by its activators, referred to as triggers. 3 Migraine occurs at all ages and may even begin in infancy. 4 The disorder begins before age 20 years in 50% of cases. 5 The prevalence of migraine may be as high as 2.5% of children less than seven years of age. By the age of 17 years as many as 8% of male and 23% of female have experienced migraine. [6] [7] [8] There are also many active migraine patients aged ≥60 years. 9 Severe disabling headache is reported to occur at least annually by 40% of individuals worldwide. 10 The morbidity associated with the millions of migraine sufferers is staggering. Approximately 64 million workdays each year are estimated to be lost in the United States due to migraine. 11 Migraine is a common recurrent primary headache disorder that has close links to the neuronal and vascular system and in some patients is accompanied by transient neurological symptoms, mostly of the visual field that are known as migraine aura. 12, 13 There is increasing evidence that migraine with aura is associated with increased risk of ischemic stroke [14] [15] [16] [17] and other vascular disease events. 18, 19 Furthermore, migraine has been associated with increased prevalence of specific cardiovascular risk factors 20, 21 including some vascular biomarkers. 22, 23 Association of migraine with other vascular risk factors, such as hypercholesterolemia has been proposed. 20 There are several explanations for the pathophysiology of migraine headache attacks. Sicuteri explained the pathogenesis of migraine headache with the dopamine hypothesis in 1977. In his hypothesis, prodromal clinical and postdromal sign-symptoms of migraine headache are attributed to increased activity of the dopaminergic system. Postsynaptic receptor hypersensitivity of the dopamine in areas of central nervous system is involved in pain, vomiting and arterial blood pressure. 24 Prolactin secretion is one measure of dopaminergic function. Dopamine decreases prolactin secretion. An abnormal pattern of hypothalamic secretion specially decreased nocturnal prolactin peak, was found in chronic migraine. 25 Administrations of dopaminergic drugs can trigger and maintain a migraine attack. 11 Dopamine antagonist may help the migraine patients.
Migraine is associated with increased prevalence of cardiovascular risk factors and vascular biomarkers and migraine with aura is associated with increased risk of ischemic stroke and other vascular disease events. Lipid abnormality is a risk factor for both cardiovascular and cerebrovascular disease. So the purpose of this study is to find out the association between lipid levels and migraine.
The vast majority of previous studies evaluated the association between lipid levels and migraine among young and middle aged persons abroad. So far we know, no study has been conducted in Bangladesh regarding association of lipid levels with migraine. The present study is aimed at to evaluate the association between lipid levels and migraine.
Material and Methods
This cross-sectional observational study was carried out in outpatient departments of Enam Medical College & Hospital, Savar, Dhaka and Mymensingh Medical College Hospital, Mymensingh from December 2017 to November 2018. A total of 100 patients (50 migraine and 50 non-migraine) were recruited in the study. Ethical clearance and permission were taken from the concerned authorities. Patients were categorized as migraineur according to International Headache Society criteria and as non-migraineur if other primary headaches, particularly tension type headache. Patients were selected by purposive sampling.
Blood samples were obtained after 12-hour fasting for lipid analysis. Plasma total cholesterol (TC), triglycerides (TG) and high density lipoprotein cholesterol (HDL-C) were measured after phosphotungstic acid precipitation, using standard enzymatic methods. Low density lipoprotein cholesterol (LDL-C) was calculated using Friedewald's formula (LDL=TC−HDLc−TG/5) (mg/dL). In case of migrainous headache males and females >18 years of age to 60 years of age, patients who satisfied the diagnosis of migraine headaches with or without aura (according to International Headache Society) and in case of non-migrainous headache, patients who did not satisfy the diagnostic criteria of migraine headache with or without aura (according to International Headache Society) and who presented with headache were included in our study. Age ≤18 years and >60 years, known structural brain disease, and patient taking lipid lowering drugs were excluded. All the relevant information were recorded in a predesigned data collection sheet. Collected data were compiled and appropriate analyses were done by using computer based software, Statistical Package for Social Sciences (SPSS) version 20.0. For statistical analysis Chi-square test, t test, ANOVA test were done. Level of significance was 5% and confidence limit was 95%.
Results
Most of the patients (40%) with migraine were in 19-30 years age group. Mean age of migraine patients was 34.20±11.35 years and non-migraine patients was 29.20±8.80 years (Table I) . Female predominance was found in both groups. In migraine group, 80% were female and in non-migraine group 76% were female. Male-female ratio was 1:4 in migraine and 1:3.16 in non-migraine group (Table II) . Serum total cholesterol and LDL were significantly higher in migraine group than in non-migraine group. HDL was below normal and triglyceride was within normal range in both groups. Their difference was not significant (p>0.05) (Table III) . Serum total cholesterol and LDL-C were significantly higher in patients with migraine with aura than patients with migraine without aura. HDL-C level was lower in patients with migraine without aura and was normal level in patients with migraine with aura, which was statistically significant. Triglyceride was normal in both groups and the difference was statistically not significant (Table IV) .
Discussion
In this study majority (80%) of the subjects were of 19-50 years of age which was similar to the findings observed by Lipton et al 26 . Mean age of migraine group was 34.20±11.35 years while non-migraine was 29.20±8.80 years. Lichten et al 27 studied a group with mean age of 37.85±1.53 years, which was higher in relation to this study. Kelman et al 28 found mean age of migraine patient 37±11.7 years which was again higher than present study. The difference may be due to geographical status and race of the patient.
In this study in migraine group 10 (20%) were male and 40 (80%) were female whereas in non-migraine group, 12 (24%) were male and 38 (76%) were female. The male female ratio was more or less same in both groups (1:4 in migraine group and 1:3.16 in nonmigraine group). Number of female in both migraine and non-migraine groups were not significantly higher than male. The male female ratio observed by Lipton et al 26 and Russel et al 29 was 1:3 and 1:2 respectively. The present study is consistent with these findings.
Regarding co-morbidity IHD, depression and stroke were found significantly higher in migraine group. But hypertension and epilepsy occurred equally in both groups (p>0.05). Kurth et al 14 found association of ischemic stroke in migraine patients. Tietjen et al 30 found association of depression with headache. The present study is consistent with these findings.
In this study group, the mean serum total cholesterol and LDL cholesterol levels were significantly higher in migraine group than in non-migraine group.
Monastero et al 31 also reported total cholesterol and LDL cholesterol significantly higher in migraine group. Pamela et al 32 found strong association of total cholesterol and triglyceride in patients with migraine. Alia et al 33 reported that hypertriglyceridemia and hypercholesterolemia were more frequent in patient with migraine. But in the present study triglyceride was found within normal range in migraine group.
Regarding migraine patient with or without aura serum cholesterol and LDL cholesterol were significantly raised in aura group. Pamela et al 32 found elevated total cholesterol in migraine with aura. The present study is almost consistent with the findings of this study.
In this study in respect of age, the mean total cholesterol was significantly higher in migraine group than in non-migraine group and more in 51-60 years Regarding LDL cholesterol level in respect of age, LDL was significantly higher in migraine group than in non-migraine group and more in 51-60 years age group. Monastero et al 31 reported that total cholesterol and LDL cholesterol were significantly higher in migraine group. Our study is consistent with the previous study.
In this study, there was no significant difference of HDL-C levels between migraine and non-migraine group in respect of age. Alia et al 33 found less incidence of low HDL cholesterol in migraine patients compared to non-migraine patients.
In this study there was no significant difference of triglyceride between two groups in respect of age. Russel et al 29 found elevated total cholesterol and triglyceride in migraine. The present study is not consistent with the findings of this study which may be due to small sample size and different food habit of the patients of two studies.
Elevated level of serum total cholesterol and LDL cholesterol were associated with migraine. Serum total cholesterol and LDL cholesterol were significantly higher in late age of migraine group and migraine with aura.
